Light and shadows of the new therapies for haemophilia treatment in the COVID-19 era

Lignende værker

• Haemophilia A/B carriers: haemorrhagic burden of disease and open issues
  af: Pasca, Samantha, et al.
  Udgivet: (2020)
• Susoctocog-alfa (Obizur(®)) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience
  af: Zanon, Ezio, et al.
  Udgivet: (2020)
• Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years
  af: Zanon, Ezio, et al.
  Udgivet: (2019)
• Therapeutic choices in persons with haemophilia at the time of COVID-19
  af: Coppola, Antonio, et al.
  Udgivet: (2020)
• Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era
  af: Burgaletto, Chiara, et al.
  Udgivet: (2021)